Skip to main content
Caplight Logo









CollimateHealth

CollimateHealth

Private
MunichHealthcare & Life Scienceshttps://collimatehealth.com

Last Round

Seed

Jun 15, 2026

Total Funding Raised

$6.9M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

CollimateHealth operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Seed round in June 2026.

CollimateHealth is a life sciences company developing a clinically scalable microbeam radiation technology for oncological treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CollimateHealth Comparables

Compare CollimateHealth with similar companies based on industry and business-model similarity.

CollimateHealth comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TibaRay
81%
ALCEN
75%
Elekta AB
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CollimateHealth Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 15, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

CollimateHealth Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 12, 2026

    $7M raised from multiple venture capital firms.

Book a demo to see all signals

For institutional investors. Book with your work email.

CollimateHealth Filings

Explore SEC and related filing metadata, where available.

CollimateHealth filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CollimateHealth's valuation, stock price, and market status.

Is CollimateHealth a public or private company?

CollimateHealth is a private company.

What is the current stock price of CollimateHealth?

CollimateHealth is a private company, so its shares have no public market price. Caplight tracks CollimateHealth's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CollimateHealth worth (valuation)?

Valuation information for CollimateHealth is not publicly available.

Can I buy CollimateHealth stock?

CollimateHealth shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CollimateHealth's last funding round?

CollimateHealth's most recent funding round was Seed on June 15, 2026.

Who are the main investors in CollimateHealth?

Key investors in CollimateHealth include Positron Ventures, xista science ventures, Caesar Ventures, VP Venture Partners, High-Tech Gründerfonds.

Will CollimateHealth IPO soon?

No public IPO plans have been announced for CollimateHealth.

How can I track CollimateHealth secondary market activity?

Caplight tracks bids, offers, and trades in CollimateHealth's shares on secondary markets.

Firmographic Details

HeadquartersMunich
Year Founded2025
Last FundingJun 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?